Table 5.
Comparison of clinical characteristics at the index visit between those with and without incident dysglycaemia and incident metabolic syndrome at the outcome visit
| Parameter | Incident dysglycaemia^ | Incident metabolic syndrome^ | ||||
|---|---|---|---|---|---|---|
| No (n = 172) |
Yes (n = 19) |
P value | No (n = 160) |
Yes (n = 21) |
P value | |
| BMI (kg/m2) |
22.4 (20.5–25.0) |
25.7 (20.8–31.1) |
0.005* |
22.0 (20.1–23.4) |
25.7 (22.7–28.8) |
< 0.001* |
| Free androgen index |
3.0 (1.8–5.0) |
5.3 (1.8–6.5) |
0.102 |
2.7 (1.7–4.3) |
3.6 (1.7–10.5) |
0.200 |
| HOMA-IR | 1.3 (0.9–1.9) | 1.6 (1.1–2.1) | 0.027* |
1.2 (0.9–1.7) |
1.6 (1.4–2.1) |
0.005* |
| AGEs (µg/ml) |
14.5 (10.2–18.7) |
17.4 (11.8–21.2) |
0.110 |
14.7 (10.2–19.4) |
14.0 (10.6–16.1) |
0.481 |
| sRAGE (pg/ml) |
629.2 (492.5–821.0) |
581.1 (436.9–866.0) |
0.656 |
661.2 (553.5–836.9) |
494.1 (469.2–700.3) |
0.008* |
^Those with existing dysglycaemia (n = 41) or metabolic syndrome (n = 51) at the index visit were excluded from the respective analyses
*Statistically significant (p < 0.05)